作者: V. R. Dharnidharka , K. E. Lamb , J. A. Gregg , H.-U. Meier-Kriesche
DOI: 10.1111/J.1600-6143.2011.03893.X
关键词: Gastroenterology 、 Internal medicine 、 Hazard ratio 、 Lymphoproliferative disorders 、 Serostatus 、 National registry 、 Organ transplantation 、 Medicine 、 Survival rate 、 Immunology 、 Increased risk 、 Single Center
摘要: In a prior multiorgan transplant database study, recipient Epstein-Barr virus (EBV) seronegativity was not associated with increased risk for posttransplant lymphoproliferative disorders (PTLD) in liver transplants (LTX), at variance single center reports and data from kidney heart (KTX HTX). The Scientific Registry of Transplant Recipients (SRTR) the United States is only other registry on required variables comparison.Our study set comprised 112 756 KTX (580 PTLDs; 0.51%), 13 937 HTX (140 1.0%) 40 437 LTX (383 0.95%) performed January 2003 onward. unadjusted hazard ratio (HR) PTLD if EBV seronegative 5.005 KTX, 6.528 2.615 (p < 0.001 all). models adjusted multiple covariates, HR 3.583 0.001) 4.037 HTX, 1.479 = 0.03) LTX. Interaction using seropositive as reference group showed significantly higher all organ groups also (AHR 2.053, p 0.0001).Recipient still LTX, though less so because baseline group.